These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38809379)

  • 1. Identification and Validation of SLC9A2 as A Potential Tumor Suppressor in Colorectal Cancer: Integrating Bioinformatics Analysis with Experimental Confirmation.
    Liu YM; Yang TC; Fang XC; Yang LJ; Shi LW; Wang HQ; Dou TT; Shu L; Chen TL; Hu J; Yu XM; Li XF
    Curr Med Sci; 2024 Jun; 44(3):529-544. PubMed ID: 38809379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The identification of a common different gene expression signature in patients with colorectal cancer.
    Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
    Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Sharma A; Yadav D; Rao P; Sinha S; Goswami D; Rawal RM; Shrivastava N
    Comput Biol Med; 2022 Jul; 146():105688. PubMed ID: 35680454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
    Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
    Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer.
    Li XN; Wang ZJ; Ye CX; Zhao BC; Li ZL; Yang Y
    J Exp Clin Cancer Res; 2018 Dec; 37(1):325. PubMed ID: 30591054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
    Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer.
    Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X
    Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
    Liang B; Li C; Zhao J
    Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
    Gao X; Yang J
    DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive Analysis of Core Genes and Potential Mechanisms in Rectal Cancer.
    Liu BX; Huang GJ; Cheng HB
    J Comput Biol; 2019 Nov; 26(11):1262-1277. PubMed ID: 31211595
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification and clinicopathological analysis of potential p73-regulated biomarkers in colorectal cancer via integrative bioinformatics.
    Bareja C; Dwivedi K; Uboveja A; Mathur A; Kumar N; Saluja D
    Sci Rep; 2024 Apr; 14(1):9894. PubMed ID: 38688978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the pivotal role of SPP1 in kidney stone disease based on multiple bioinformatics analysis.
    Hong SY; Xia QD; Xu JZ; Liu CQ; Sun JX; Xun Y; Wang SG
    BMC Med Genomics; 2022 Jan; 15(1):7. PubMed ID: 35016690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of gene expression data identifies key genes and pathways in colorectal cancer.
    Hozhabri H; Lashkari A; Razavi SM; Mohammadian A
    Med Oncol; 2021 Jan; 38(1):7. PubMed ID: 33411100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.